|
|
|
Insider
Information: |
Mirviss Jeffrey B. |
Relationship: |
EVP&Pres, Periph Inter... |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
58,098 |
|
Indirect Shares
|
25,000 |
|
|
Direct
Value |
$4,331,206 |
|
|
Indirect Value
|
$1,863,750 |
|
|
Total
Shares |
83,098 |
|
|
Total
Value |
$6,194,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP&Pres, Periph Inter... |
2024-03-18 |
58,098 |
2020-09-03 |
25,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-09-01 |
4 |
OE |
$6.31 |
$378,600 |
D/D |
60,000 |
175,622 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-09-01 |
4 |
AS |
$40.93 |
$2,456,028 |
D/D |
(60,000) |
115,622 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-04-28 |
4 |
OE |
$7.39 |
$357,964 |
D/D |
48,439 |
187,597 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-04-28 |
4 |
AS |
$43.98 |
$2,130,347 |
D/D |
(48,439) |
139,158 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-01 |
4 |
OE |
$7.16 |
$333,541 |
D/D |
46,584 |
178,067 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2020-12-01 |
4 |
AS |
$33.53 |
$1,562,106 |
D/D |
(46,584) |
131,483 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
AS |
$46.15 |
$1,893,504 |
D/D |
(41,032) |
99,559 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
37,212 |
119,747 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2018-07-10 |
4 |
AS |
$34.00 |
$1,139,415 |
D/D |
(33,512) |
89,162 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2018-07-10 |
4 |
OE |
$8.30 |
$278,150 |
D/D |
33,512 |
122,674 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
OE |
$13.08 |
$387,155 |
D/D |
29,599 |
140,591 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-04-15 |
4 |
AS |
$40.95 |
$1,151,640 |
D/D |
(28,123) |
139,158 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2021-04-15 |
4 |
OE |
$6.28 |
$176,612 |
D/D |
28,123 |
167,281 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
83,254 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2017-02-28 |
4 |
S |
$24.67 |
$616,663 |
D/D |
(25,000) |
78,675 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,846 |
110,784 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2016-05-06 |
4 |
S |
$21.94 |
$541,038 |
D/D |
(24,659) |
71,975 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
23,174 |
97,512 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
21,458 |
107,315 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4/A |
S |
$11.87 |
$237,402 |
D/D |
(20,000) |
65,190 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4/A |
OE |
$6.31 |
$126,200 |
D/D |
20,000 |
85,190 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4 |
S |
$11.87 |
$237,402 |
D/D |
(20,000) |
45,190 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2018-06-14 |
4 |
AS |
$32.64 |
$630,703 |
D/D |
(19,323) |
89,162 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,869 |
88,607 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP&Pres, Periph Intervent |
|
2016-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,866 |
99,128 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|